Physician profile
Jesse A Larbey
NPI 1194095448
$2,533.75
in general payments reported to CMS, 2019-2025
38 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $500 · 2022: $1,307 · 2023: $184 · 2024: $259 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,037.67 | 2022-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $108.97 | 2021-2024 | Xtandi, Myrbetriq |
| Novo Nordisk INC | $92.23 | 2021 | |
| Janssen Biotech, INC. | $89.30 | 2022-2025 | Erleada |
| Urogen Pharma, INC. | $79.65 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $70.85 | 2021-2024 | Lynparza |
| Olympus America INC. | $70.21 | 2023-2025 | Itind System |
| 180 Medical, INC. | $67.20 | 2022-2024 | Gentlecath, Cure Catheter |
| Collegium Pharmaceutical, INC. | $66.13 | 2021 | |
| Dendreon Pharmaceuticals LLC | $63.87 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $63.79 | 2021-2022 | |
| Pfizer INC. | $62.88 | 2021-2025 | |
| Amarin Pharma, INC. | $51.61 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.73 | 2021-2022 | |
| Glaxosmithkline, LLC. | $50.25 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $49.04 | 2024 | Orgovyx |
| Coloplast Corp | $48.25 | 2023-2025 | Speedicath |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.73 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.94 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $25.67 | 2021 | |
| Accord Healthcare, INC. | $24.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.31 | 2021 | |
| Endo USA, INC. | $22.80 | 2025 | Xiaflex |
| Myovant Sciences INC. | $22.72 | 2022 | |
| Boston Scientific Corporation | $18.77 | 2025 | Spaceoar Vue System - 10ml |
| Abbott Laboratories | $18.60 | 2022 | |
| Daiichi Sankyo INC. | $17.83 | 2021 | |
| Medtronic, INC. | $17.39 | 2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $16.37 | 2022 | |
| Telix Pharmaceuticals | $16.27 | 2023 | Illuccix |
| Tolmar, INC. | $16.00 | 2023 | |
| Lilly USA, LLC | $14.53 | 2022 | |
| Abbvie INC. | $13.72 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.52 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.13 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $12.04 | 2022 | |
| Mylan Specialty L.P. | $11.95 | 2022 | |
| Organon LLC | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Larbey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.